恒瑞医药(01276.HK)11月20日耗资1274.32万元回购20.99万股A股

Core Viewpoint - Heng Rui Medicine (01276.HK) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company plans to repurchase 209,900 A-shares at a total cost of RMB 12.7432 million [1] - The buyback price per share is set between RMB 60.58 and RMB 60.78 [1]